Staurosporine drives non‐canonical melanocyte maturation through β‐catenin‐dependent actin remodeling. Functional maturation enhances dendrite architecture and melanogenic differentiation without inducing melanocyte proliferation, providing a biological framework for restoring functional melanocytes in acquired hypopigmentary disorders.
Kangning Xu +6 more
wiley +1 more source
Botulinum Toxin Type A as an Early Intervention for Traumatic Oculomotor Nerve Palsy: A Pediatric Case Report. [PDF]
Koiwa C +4 more
europepmc +1 more source
Botulinum Toxin Type A Injections in the Bladder Wall-An Effective Treatment for Urinary Incontinence with Low Long-Term Adherence. [PDF]
Cruz F, Michel MC, Igawa Y.
europepmc +1 more source
Beyond Conventional Analgesics: Updated Evidence Supporting Botulinum Toxin Type A for-Neuralgia Management. [PDF]
Yu JT, Li CP, Huang TM, Tsai RY.
europepmc +1 more source
Botulinum Toxin Type A for the Prevention of Migraines: An Umbrella Review of Systematic Reviews. [PDF]
Chamani G +10 more
europepmc +1 more source
Journal of Cosmetic Dermatology, Volume 25, Issue 9, September 2026.
Aslan Yurekli, Ismail Hakki Unal
wiley +1 more source
Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis. [PDF]
Cheng N +3 more
europepmc +1 more source
Journal of Cosmetic Dermatology, Volume 25, Issue 9, September 2026.
Phyo Zaw Aung, Thamthiwat Nararatwanchai
wiley +1 more source
Botulinum toxin type A attenuates trigeminal neuralgia-like pain by suppressing CGRP release and modulating NaV1.7-associated signaling. [PDF]
Yao MH +9 more
europepmc +1 more source

